| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681836 | Clinical Neurology and Neurosurgery | 2018 | 21 Pages |
Abstract
Stand-alone anterior lumbar interbody fusion using hydroxyapatite nanoparticles without an autologous bone graft is an effective and safe treatment option for L5-S1 degenerative pathology. Clinical outcomes were very satisfactory with a high fusion rate.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Gilles Norotte, Carlos Barrios,